GlassScriptPhysician profile
Randal Joseph Herbert
NPI 1356781819
$4,362.04
in general payments reported to CMS, 2019-2025
24 companies · $1,668 in 2025
The $1,668 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $629 · 2023: $937 · 2024: $826 · 2025: $1,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,431.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $579.44 | 2022-2025 | Wegovy, Ozempic |
| Abbvie INC. | $412.75 | 2021-2023 | |
| Gilead Sciences, INC. | $345.48 | 2022-2025 | Epclusa |
| Alexion Pharmaceuticals, INC. | $259.95 | 2023-2025 | Strensiq |
| Teva Pharmaceuticals USA, INC. | $249.99 | 2022-2024 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $247.12 | 2022-2024 | Wainua |
| Genzyme Corporation | $199.61 | 2024-2025 | |
| Dexcom, INC. | $163.44 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Medtronic, INC. | $150.92 | 2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $139.67 | 2025 | |
| Organon LLC | $137.77 | 2025 | Vtama |
| Janssen Biotech, INC. | $136.78 | 2025 | |
| Phathom Pharmaceuticals, INC. | $124.99 | 2024 | Voquezna |
| Sanofi Pasteur INC. | $124.97 | 2023 | |
| Neurelis, INC. | $123.56 | 2024 | Valtoco |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $123.19 | 2025 | Rezdiffra |
| Idorsia Pharmaceuticals US INC | $120.39 | 2023 | Quviviq |
| Sage Therapeutics, LLC | $118.36 | 2023 | |
| Janssen Pharmaceuticals, INC | $115.06 | 2024 | Spravato |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.00 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $100.00 | 2021 | |
| Itamar Medical INC | $98.22 | 2023 | Watchpatone |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $98.06 | 2025 | |
| Boston Scientific Corporation | $92.32 | 2025 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randal Herbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.